Written medicine information from English-speaking countries - How does it compare?

Annals of Pharmacotherapy

Volumn 44, Issue 2, 2010, Pages 285-294

  Luk, Alice ^a   Tasker, Natalie ^a   Raynor, David K Theo ^b   Aslani, Parisa ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Consumer medicine information; Evaluation criteria; Format; Readability; Written medicine information

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; DICLOFENAC; GLYCERYL TRINITRATE; HYDROCORTISONE; HYDROCORTISONE ACETATE; ISOTRETINOIN; KETOTIFEN; KETOTIFEN FUMARATE; LEFLUNOMIDE; LIPOCORT; LORATADINE; MAXTREX; METFORMIN; METHOTREXATE; METOMIN; NON PRESCRIPTION DRUG; ORATANE; PERINDOPRIL; SALMETEROL; SALMETEROL XINAFOATE; SERTRALINE; SIMVASTATIN; UNCLASSIFIED DRUG;

ACNE; ANGINA PECTORIS; ARTHRALGIA; ARTICLE; ASTHMA; AUSTRALIA; CANADA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONJUNCTIVITIS; CONSUMER HEALTH INFORMATION; DEPRESSION; DRUG INFORMATION; DYSMENORRHEA; ECZEMA; HEART FAILURE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFECTION; IRELAND; MIGRAINE; NEW ZEALAND; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSESSIVE COMPULSIVE DISORDER; PANIC; PATIENT COMPLIANCE; PHOBIA; PRESCRIPTION; PRIORITY JOURNAL; PSORIASIS; READING; RHEUMATOID ARTHRITIS; SKIN INFLAMMATION; TREATMENT INDICATION; UNITED KINGDOM; UNITED STATES;

COMPREHENSION; DRUG LABELING; GUIDELINE ADHERENCE; HUMANS; LANGUAGE; PAMPHLETS; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC;

EID: 76149117198     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M402     Document Type: Article

References (28)

1. Gordon K, Smith F, Dhillon S. Effective chronic disease management: patients' perspectives on medication-related problems. Patient Educ Couns 2007;65:407-15. DOI 10.1016/j.pec.2006.09.012
2. Johannson K, Salanterä S, Katajisto J. Empowering orthopaedic patients through preadmission education: results from a clinical study. Patient Educ Couns 2007;66:84-91. DOI 10.1016/j.pec.2006.10.011
3. Sheard C, Garrud P. Evaluation of generic patient information: effects on health outcomes, knowledge and satisfaction. Patient Educ Couns 2006; 61:43-7. DOI 10.1016/j.pec.2005.02.004
4. Sless D, Shrensky R. Writing about medicines for people. Canberra: Australian Self-Medication Industry, 2006.
5. Food and Drug Administration. Guidance on useful consumer medication information (CMI). Rockville, MD: US Department of Health and Human Services, 2006.
6. The European Parliament and the Council of the European Union. Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use. Off J Eur Union; 2004. p. Legislation 36;34-57.
7. Weiss BD, Coyne C, Michielutte R, Davis TC, Meade CD, Doak CC. Communicating with patients who have limited literacy skills: report of the national working group on literacy and health. J Fam Pract 1998; 46:168-76.
8. Shea JA, Guerra CE, Ravenell KL, McDonald VJ, Henry CAN, Asch DA. Health literacy weakly but consistently predicts primary care patient dissatisfaction. Int J Qual Health Care 2007;19:45-9. DOI 10.1093/intqhc/mzl068
9. Bevan JL, Pecchioni LL. Understanding the impact of family caregiver cancer literacy on patient health outcomes. Patient Educ Couns 2008;71:356-64. DOI 10.1016/j.pec.2008.02.022
10. Schillinger D, Bindman A, Wang F, Stewart A, Piette J. Functional health literacy and the quality of physician-patient communication among diabetes patients. Patient Educ Couns 2004;52:315-23. DOI 10.1016/S0738-3991(03)00107-1
11. Wolf MS, Davis TC, Osborn CY, Skripkauskas S, Bennett CL, Makoul G. Literacy, self-efficacy, and HIV medication adherence. Patient Educ Couns 2007;65:253-60.
12. Baker SJ. Who can read consumer product information? Aust J Hosp Pharm 1997;27:126-31.
13. Koo MM, Krass I, Aslani P. Factors influencing consumer use of written drug information. Ann Pharmacother 2003;37:259-67. DOI 10.1345/aph.1C328
14. Roskos SE, Wallace LS, Weiss BD. Readability of consumer medication information for intranasal corticosteroid inhalers. Am J Health Syst Pharm 2008;65:65-8.
15. Raynor DK, Savage I, Knapp P, Henley J. We are experts: people with asthma talk about their medicine information needs. Patient Educ Couns 2004;53:167-74. DOI 10.1016/S0738-3991(03)00126-5
16. Krass I, Svarstad BL, Bultman D. Using alternative methodologies for evaluating patient medication leaflets. Patient Educ Couns 2002;47:29-35. DOI 10.1016/S0738-3991(01)00171-9
17. Raynor DK, Svarstad BL, Knapp P, et al. Consumer medication information in the United States, Europe, and Australia: a comparative evaluation. J Am Pharm Assoc 2007;47:717-24.
18. Steering Committee for the Collaborative Development of a Long-Range Action Plan for the Provision of Useful Prescription Medicine Information. Action plan for the provision of useful prescription medicine information. US Department of Health and Human Services; 1996 cited in FDA Guidance on Useful Written Consumer Medication Information. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatory-Information/Guidances/ucm080602.pdf (accessed 2009 Nov 10).
19. Raynor DK, Blenkinsopp A, Knapp P, et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technol Assess 2007;11.
20. Mullan JR, Crookes PA, Yeatman HR. RAIN, SMOG, FOG and printed educational materials. J Pharm Pract Res 2003;33:284-6.
21. Eames S, McKenna K, Worrall L, Read S. The suitability of written education materials for stroke survivors and their carers. Top Stroke Rehabil 2003;10:70-83.
22. Flesch R. A new readability yardstick. J Appl Psychol 1948;32:221-33.
23. Gunning R. The technique of clear writing. New York: McGraw-Hill International Book Co., 1968.
24. Svarstad BL, Mount JK, Tabak ER. Expert and consumer evaluation of patient medication leaflets provided in US pharmacies. J Am Pharm Assoc 2005;47:717-24.
25. Meade CD, Smith CF. Readability formulas: cautions and criteria. Patient Educ Couns 1991;17:153-8. DOI 10.1016/0738-3991(91)90017-Y
26. SPSS Inc. Statistical Package for the Social Sciences. Rel. 16.0.1. Chicago, 2007.
27. New Zealand Medicines and Medical Devices Safety Authority. New Zealand Regulatory Guidelines for Medicines. 3rd ed., September, 2001.
28. United Nations Educational Scientific and Cultural Organization. Appendix A: the education systems of the G-8 countries. In: Comparative indicators of education in the United States and other G-8 countries: 2006; 2007. Document No.: NCES 2007006.